We hypothesized that the new synthetic oral hypoglycemic would increase liver insulin sensitivity due to the activation of the ACE 2/Ang (1–7)/PI3K/AKT/mTOR axis on experimentally high-fat diet-induced diabetes in albino Wistar rats. The gene discussed is MTOR; the disease is diabetes mellitus.